Keri M. Sullivan

1.9k total citations · 1 hit paper
4 papers, 311 citations indexed

About

Keri M. Sullivan is a scholar working on Oncology, Infectious Diseases and Neurology. According to data from OpenAlex, Keri M. Sullivan has authored 4 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Infectious Diseases and 1 paper in Neurology. Recurrent topics in Keri M. Sullivan's work include Cancer Immunotherapy and Biomarkers (2 papers), Ethics in Clinical Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Keri M. Sullivan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Ethics in Clinical Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Keri M. Sullivan collaborates with scholars based in United States. Keri M. Sullivan's co-authors include Michael Dougan, Genevieve M. Boland, Tatyana Sharova, Kai W. Wucherpfennig, Osama E. Rahma, F. Stephen Hodi, Shengbao Suo, Peter J. Bowling, Jonathan A. Nowak and Ryan J. Sullivan and has published in prestigious journals such as Cell, Contemporary Clinical Trials and Open Forum Infectious Diseases.

In The Last Decade

Keri M. Sullivan

3 papers receiving 310 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

2020 307 citations Adrienne Luoma, Shengbao Suo et al. Cell profile →

Peers

Countries citing papers authored by Keri M. Sullivan

Since Specialization

Citations

This map shows the geographic impact of Keri M. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keri M. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keri M. Sullivan more than expected).

Fields of papers citing papers by Keri M. Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keri M. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keri M. Sullivan. The network helps show where Keri M. Sullivan may publish in the future.

Co-authorship network of co-authors of Keri M. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Keri M. Sullivan. A scholar is included among the top collaborators of Keri M. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keri M. Sullivan. Keri M. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

#	Work	Indexed citations
1	The Development of Persistent Gastrointestinal Symptoms in Patients With Melanoma Who Have Had an Immune Checkpoint Inhibitor-Related Gastrointestinal Toxicity 2024 ·Clinical and Translational Gastroenterology ·Sanskriti Varma, Keri M. Sullivan, (unknown), (unknown), Kyle Staller, Michael Dougan	0
2	The association between non-English primary language and COVID-19 clinical trial eligibility and enrollment: A retrospective cohort study 2022 ·Contemporary Clinical Trials ·Sarah Tait, Chana A. Sacks, Michael Dougan, Keri M. Sullivan, Alexander C. Tsai, Thomas H. McCoy, Crystal M. North	2
3	Performance of a Triage Protocol for Monoclonal Antibodies in a Mixed Vaccinated and Unvaccinated Cohort of COVID-19 Patients Treated With Intravenous Infusion or Subcutaneous Injection 2022 ·Open Forum Infectious Diseases ·Emily Rubin, (unknown), Anita Giobbie‐Hurder, (unknown), (unknown), Keri M. Sullivan, Michael Dougan	2
4	Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy breakdown → 2020 ·Cell ·Adrienne Luoma, Shengbao Suo, Hannah L. Williams, Tatyana Sharova, Keri M. Sullivan, Michael P. Manos, Peter J. Bowling, F. Stephen Hodi, Osama E. Rahma, Ryan J. Sullivan, Genevieve M. Boland, Jonathan A. Nowak, Stephanie K. Dougan, Michael Dougan, Guo‐Cheng Yuan, Kai W. Wucherpfennig	307

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact